Skip to content

Maxima 4 Wheel SC941Recalls & reported problems

Pride Mobility Products Corp · A motorized three-wheeled vehicle is a gasoline-fueled or battery-powered device intended for medical purposes that is used for outside transportation by disabled persons. · Class 2

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00606509300551), received between Jul 20, 2022 and Nov 16, 2022 — classified as 2 injuries.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Appropriate Device Problem Term/Code Not Available2

Patient problems

  • Bone Fracture(s)1
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 16, 2022Appropriate Device Problem Term/Code Not Available; Appropriate Device Problem Term/Code Not Available

    PROVIDER ALLEGES CONSUMER WAS DRIVING DOWN A SIDEWALK WHEN THE WELD ON THE SEAT POST ALLEGEDLY BROKE ALLEGEDLY CAUSING THE CONSUMER TO FALL OUT OF THE CHAIR.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15805340 ↗
  • InjuryJul 20, 2022Appropriate Device Problem Term/Code Not Available; Appropriate Device Problem Term/Code Not Available

    PROVIDER ALLEGES CONSUMER HIT A PEBBLE AND THE STEERING WAS ALLEGEDLY OFF. THE SCOOTER ALLEGEDLY TOOK OFF AND FLIPPED OVER WITH THE CONSUMER IN IT.

    Patient problems: Bone Fracture(s)

    MAUDE report 15067795 ↗

Other Vehicle, Motorized 3-Wheeled devices

All Vehicle, Motorized 3-Wheeled devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.